{
    "name": "Schedule IV",
    "number": "20",
    "text": "\u00a7329-20\u00a0 Schedule IV.\u00a0 (a)\u00a0 The controlled substances listed in this section are included in schedule IV.\n\u00a0\u00a0\u00a0\u00a0 (b)\u00a0 Depressants.\u00a0 Any material, compound, mixture, or preparation which contains any quantity of the following substances, including its salts, isomers, esters, ethers, and salts of isomers, whenever the existence of these isomers, esters, ethers, and salts is possible within the specific chemical designation, that has a degree of danger or probable danger associated with a depressant effect on the central nervous system:\n\u00a0\u00a0\u00a0\u00a0 (1)\u00a0 Alprazolam;\n\u00a0\u00a0\u00a0\u00a0 (2)\u00a0 Barbital;\n\u00a0\u00a0\u00a0\u00a0 (3)\u00a0 Bromazepam;\n\u00a0\u00a0\u00a0\u00a0 (4)\u00a0 Butorphanol;\n\u00a0\u00a0\u00a0\u00a0 (5)\u00a0 Camazepam;\n\u00a0\u00a0\u00a0\u00a0 (6)\u00a0 Carisoprodol;\n\u00a0\u00a0\u00a0\u00a0 (7)\u00a0 Chloral betaine;\n\u00a0\u00a0\u00a0\u00a0 (8)\u00a0 Chloral hydrate;\n\u00a0\u00a0\u00a0\u00a0 (9)\u00a0 Chlordiazepoxide;\n\u00a0\u00a0\u00a0 (10)\u00a0 Clobazam;\n\u00a0\u00a0\u00a0 (11)\u00a0 Clonazepam;\n\u00a0\u00a0\u00a0 (12)\u00a0 Clorazepate;\n\u00a0\u00a0\u00a0 (13)\u00a0 Clotiazepam;\n\u00a0\u00a0\u00a0 (14)\u00a0 Cloxazolam;\n\u00a0\u00a0\u00a0 (15)\u00a0 Delorazepam;\n\u00a0\u00a0\u00a0 (16)\u00a0 Dichloralphenazone (Midrin);\n\u00a0\u00a0\u00a0 (17)\u00a0 Diazepam;\n\u00a0\u00a0\u00a0 (18)\u00a0 Estazolam;\n\u00a0\u00a0\u00a0 (19)\u00a0 Ethchlorvynol;\n\u00a0\u00a0\u00a0 (20)\u00a0 Ethinamate;\n\u00a0\u00a0\u00a0 (21)\u00a0 Ethyl loflazepate;\n\u00a0\u00a0\u00a0 (22)\u00a0 Fludiazepam;\n\u00a0\u00a0\u00a0 (23)\u00a0 Flunitrazepam;\n\u00a0\u00a0\u00a0 (24)\u00a0 Flurazepam;\n\u00a0\u00a0\u00a0 (25)\u00a0 Fospropofol (Lusedra);\n\u00a0\u00a0\u00a0 (26)\u00a0 Halazepam;\n\u00a0\u00a0\u00a0 (27)\u00a0 Haloxazolam;\n\u00a0\u00a0\u00a0 (28)\u00a0 Ketazolam;\n\u00a0\u00a0\u00a0 (29)\u00a0 Loprazolam;\n\u00a0\u00a0\u00a0 (30)\u00a0 Lorazepam;\n\u00a0\u00a0\u00a0 (31)\u00a0 Lormetazepam;\n\u00a0\u00a0\u00a0 (32)\u00a0 Mebutamate;\n\u00a0\u00a0\u00a0 (33)\u00a0 Medazepam;\n\u00a0\u00a0\u00a0 (34)\u00a0 Meprobamate;\n\u00a0\u00a0\u00a0 (35)\u00a0 Methohexital;\n\u00a0\u00a0\u00a0 (36)\u00a0 Methylphenobarbital (mephorbarbital);\n\u00a0\u00a0\u00a0 (37)\u00a0 Midazolam;\n\u00a0\u00a0\u00a0 (38)\u00a0 Nimetazepam;\n\u00a0\u00a0\u00a0 (39)\u00a0 Nitrazepam;\n\u00a0\u00a0\u00a0 (40)\u00a0 Nordiazepam;\n\u00a0\u00a0\u00a0 (41)\u00a0 Oxazepam;\n\u00a0\u00a0\u00a0 (42)\u00a0 Oxazolam;\n\u00a0\u00a0\u00a0 (43)\u00a0 Paraldehyde;\n\u00a0\u00a0\u00a0 (44)\u00a0 Petrichloral;\n\u00a0\u00a0\u00a0 (45)\u00a0 Phenobarbital;\n\u00a0\u00a0\u00a0 (46)\u00a0 Pinazepam;\n\u00a0\u00a0\u00a0 (47)\u00a0 Prazepam;\n\u00a0\u00a0\u00a0 (48)\u00a0 Quazepam;\n\u00a0\u00a0\u00a0 (49)\u00a0 Suvorexant;\n\u00a0\u00a0\u00a0 (50)\u00a0 Temazepam;\n\u00a0\u00a0\u00a0 (51)\u00a0 Tetrazepam;\n\u00a0\u00a0\u00a0 (52)\u00a0 Triazolam;\n\u00a0\u00a0\u00a0 (53)\u00a0 Zaleplon;\n\u00a0\u00a0\u00a0 (54)\u00a0 Zolpidem; and\n\u00a0\u00a0\u00a0 (55)\u00a0 Zopiclone (Lunesta).\n\u00a0\u00a0\u00a0\u00a0 (c)\u00a0 Fenfluramine.\u00a0 Any material, compound, mixture, or preparation which contains any quantity of the following substances, including its salts, isomers, and salts of isomers, whenever the existence of such salts, isomers, and salts of isomers is possible:\u00a0 Fenfluramine.\n\u00a0\u00a0\u00a0\u00a0 (d)\u00a0 Stimulants.\u00a0 Unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a stimulant effect on the central nervous system, including its salts, isomers, and salts of such isomers whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation:\n\u00a0\u00a0\u00a0\u00a0 (1)\u00a0 Cathine ((+)-norpseudoephedrine);\n\u00a0\u00a0\u00a0\u00a0 (2)\u00a0 Diethylpropion;\n\u00a0\u00a0\u00a0\u00a0 (3)\u00a0 Fencamfamin;\n\u00a0\u00a0\u00a0\u00a0 (4)\u00a0 Fenproporex;\n\u00a0\u00a0\u00a0\u00a0 (5)\u00a0 Mazindol;\n\u00a0\u00a0\u00a0\u00a0 (6)\u00a0 Mefenorex;\n\u00a0\u00a0\u00a0\u00a0 (7)\u00a0 Modafinil;\n\u00a0\u00a0\u00a0\u00a0 (8)\u00a0 Phentermine;\n\u00a0\u00a0\u00a0\u00a0 (9)\u00a0 Pemoline (including organometallic complexes and chelates thereof);\n\u00a0\u00a0\u00a0 (10)\u00a0 Pipradrol;\n\u00a0\u00a0\u00a0 (11)\u00a0 Sibutramine;\n\u00a0\u00a0\u00a0 (12)\u00a0 SPA (1-dimethylamino-1,2-diphenylethane, lefetamine); and\n\u00a0\u00a0\u00a0 (13)\u00a0 Lorcaserin.\n\u00a0\u00a0\u00a0\u00a0 (e)\u00a0 Other substances.\u00a0 Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances, including its optical isomers and its salts, isomers, and salts of isomers: \n\u00a0\u00a0\u00a0\u00a0 (1)\u00a0 Pentazocine; and\n\u00a0\u00a0\u00a0\u00a0 (2)\u00a0 Eluxadoline (5-[[[(2S)-2-amino-3-[4-aminocarbonyl)-2,6-dimethylphenyl]-1-oxopropyl][(1S)-1-(4-phenyl-1H-imidazol-2-yl)ethyl]amino]methyl]-2-methoxybenzoic acid.\n\u00a0\u00a0\u00a0\u00a0 (f)\u00a0 The department of public safety may except by rule any compound, mixture, or preparation containing any depressant substance listed in subsection (b) or any stimulant listed in subsection (d) from the application of all or any part of this chapter if the compound, mixture, or preparation contains one or more active medicinal ingredients not having a depressant or stimulant effect on the central nervous system, and if the admixtures are included therein in combinations, quantity, proportion, or concentration that vitiate the degree of danger or probable danger of the substances which have a depressant or stimulant effect on the central nervous system.\n\u00a0\u00a0\u00a0\u00a0 (g)\u00a0 Narcotic drugs.\u00a0 Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation containing any of the following narcotic drugs, or their salts calculated as the free anhydrous base or alkaloid, in limited quantities as set forth below:\n\u00a0\u00a0\u00a0\u00a0 (1)\u00a0 Not more than one milligram of difenoxin and not less than twenty-five micrograms of atropine sulfate per dosage unit; \n\u00a0\u00a0\u00a0\u00a0 (2)\u00a0 Dextropropoxyphene (alpha-(+)-4-dimethylamino-1, 2-diphenyl-3-methyl-2-propionoxybutane); and\n\u00a0\u00a0\u00a0\u00a0 (3)\u00a0 2-[(dimethylamino)methyl]-1-(3-methoxyphenyl)cyclohexanol, its salts, optical and geometric isomers and salts of these isomers (including tramadol). [L 1972, c 10, pt of \u00a71; am L 1973, c 184, \u00a71; am L 1974, c 217, \u00a74; am L 1977, c 116, \u00a73; am L 1978, c 68, \u00a75; am L 1979, c 194, \u00a73; am L 1980, c 140, \u00a72; am L 1985, c 150, \u00a73; am L 1987, c 203, \u00a72; am L 1990, c 281, \u00a710; am L 1993, c 9, \u00a71; am L 1995, c 122, \u00a74; am L 2000, c 98, \u00a75; am L 2001, c 203, \u00a75; am L 2002, c 165, \u00a72; am L 2003, c 151, \u00a75; am L 2006, c 171, \u00a71; am L 2008, c 119, \u00a75; am L 2010, c 123, \u00a73; am L 2014, c 54, \u00a73; am L 2015, c 195, \u00a73; am L 2016, c 218, \u00a74]"
}